Komori
Collabos (3908) · RiskSoftened

Impact of COVID-19 Spread on Business Activities and Medium-Term Plan

First written in FY2020. 7 of 17 entries say "Restated". Latest entry: FY2026.

17entries
7years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q2 – FY2023MaterialisedFY2024-Q1 – FY2024SoftenedFY20252020: 320202021: 220212022: 320222023: 420232024: 220242025: 120252026: 22026
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026SoftenedAnnual report

    「If our business locations or the data centers with which we have contracts are damaged by natural disasters such as earthquakes, typhoons and tsunamis, fires, or the spread of infectious diseases, our business and results of operations may be affected.」

    The impact of COVID-19 on project volumes and the medium-term plan was not expressly disclosed, and the disclosure remained limited to general risk language concerning natural disasters and infectious diseases.
  2. 2026-06-03Cited as achievedFinancial Results Presentation

    「We failed to anticipate the negative rebound decline accompanying the end of specific demand.」

    As a factor behind the failure to achieve the medium-term management plan, the company identified the continuation of specific demand associated with the COVID-19 response and the subsequent negative rebound decline as past external factors. This does not indicate an expansion of current infectious-disease risk.
  3. FY2025SoftenedAnnual report

    「If our business locations or the data centers with which we have contracts are damaged by natural disasters such as earthquakes, typhoons and tsunamis, fires, or the spread of infectious diseases, our business and results of operations may be affected.」

    The specific disclosures in prior years regarding the contraction of projects and impact on the medium-term plan caused by COVID-19 were not expressly included in this filing, which reverted to general risk language concerning natural disasters and infectious diseases.
  4. FY2024Full-year impact of the contraction in infectious-disease-related projectsAnnual report

    「Meanwhile, the decline in monthly usage fees, mainly due to the reduction in seats for large projects at "@nyplace," as well as delayed revenue contributions from new services such as "VLOOM" and "GROWCE" due to lost opportunities for prospective new contracts and the postponement of order timing resulting from delays in service releases from the original schedule, had a significant impact on performance for the fiscal year under review.」

    The decline in sales resulting from reduced activity in one-off public-sector projects related to COVID-19 and other factors also affected full-year performance. In addition, the company disclosed lost opportunities and delayed revenue contributions resulting from delays in the release of new services.
  5. FY2024-Q3Continuing impact of the contraction in infectious-disease-related projectsAnnual report

    「Meanwhile, the decline in sales, mainly due to reduced activity in one-off public-sector projects related to COVID-19, had a significant impact on performance for the cumulative third-quarter period.」

    The decline in sales due to reduced activity in one-off public-sector projects related to COVID-19 and other factors continued, with cumulative FY2024-Q3 net sales of ¥1,629.607 million, down 6.6% year on year. The impact of the contraction in infectious-disease-related projects on performance continued.
  6. FY2024-Q2MaterialisedAnnual report

    「Meanwhile, sales also declined due to a reduction in one-off public-sector projects related to COVID-19. As a result, net sales for the cumulative second-quarter period were ¥1,105.770 million, down 5.4% year on year.」

    The continued reduction in one-off public-sector projects related to COVID-19 was reflected in cumulative FY2024-Q2 performance as lower sales.
  7. FY2024-Q1MaterialisedAnnual report

    「Meanwhile, sales also declined due to a reduction in one-off public-sector projects related to COVID-19. As a result, net sales for the cumulative first-quarter period were ¥555.841 million, down 4.4% year on year.」

    The company stated that the reduction in one-off public-sector projects related to COVID-19 had actually resulted in lower sales. The contraction of infectious-disease-related projects was reflected in business performance.
  8. FY2023RestatedAnnual report

    「We have adopted a working arrangement that combines office work with telework from home and are operating our business while monitoring future market conditions. However, if a renewed spread of the outbreak or the emergence of a new virus causes IT investment to slow amid an economic downturn, sales activities targeting new customers may be affected and the medium-term management plan announced in May 2023 may fail to progress as planned, which could affect our business and results of operations.」

    The company continues to identify the risk that a renewed spread of infectious diseases or the spread of a new virus could affect IT investment, efforts to acquire new customers and progress under the new medium-term management plan.
  9. FY2023-Q3RestatedAnnual report

    「During the cumulative third-quarter period, Japan's economy gradually recovered, although the situation regarding COVID-19 repeatedly cycled between deterioration and improvement, supported by the easing of restrictions on activities and the recovery of overseas economies. However, the domestic economic environment remains uncertain due to the impact of higher prices resulting from the weaker yen, supply-side constraints and developments in COVID-19.」

    While recognizing the recovery in economic activity resulting from the easing of restrictions on activities and other factors, the company stated that uncertainty continues due to developments in infectious diseases, higher prices and supply constraints.
  10. FY2023-Q1RestatedAnnual report

    「During the first three months of the fiscal year, Japan’s economy showed signs of recovery as economic and social activity normalized following comprehensive measures to prevent COVID-19 infections. However, the domestic and overseas economic environment remained uncertain due to the prolonged situation in Ukraine, the impact of soaring prices caused by record yen depreciation, and the renewed spread of COVID-19.」

    The company stated that, while recognizing the normalization of economic and social activity, an uncertain economic environment, including a renewed spread of COVID-19, continues.
  11. FY2022RestatedAnnual report

    「We have implemented measures including moving sales activities and seminars online and discouraging commuting by establishing a work-from-home environment, and we will continue operating our business while monitoring future market conditions. However, if it takes time for the situation to be brought under control, we anticipate that a slowdown in IT investment accompanying an economic downturn could affect sales activities targeting new customers, and that the medium-term management plan announced in May 2020 may fail to progress as planned, which could affect our business and results of operations.」

    The company continues to identify the prolonged infectious disease as a risk to sales activities, IT investment and the medium-term management plan, and cites moving sales activities and seminars online and establishing a work-from-home environment as countermeasures.
  12. FY2022-Q3RestatedAnnual report

    「However, economic trends must continue to be monitored closely because of risks including the adverse effects of economic stagnation caused by activity restrictions and requests to refrain from going out due to COVID-19, including new variants, supply-side constraints, and soaring raw-material prices.」

    While recognizing the recovery in economic activity, the company stated that uncertainty continues due to variant strains, activity restrictions, requests to refrain from going out, supply constraints and higher raw material prices.
  13. FY2022-Q2RestatedAnnual report

    「During the cumulative second-quarter period, Japan's economy remained in a difficult situation due to the impact of COVID-19. However, corporate sentiment has been improving, mainly in manufacturing, due to progress in vaccinations and improvements in overseas economies. Meanwhile, the earnings environment has remained difficult in non-manufacturing industries as a result of some restrictions on economic activity, and the situation remains uncertain, with personal consumption and employment continuing to show mixed movements.」

    While recognizing improvements resulting from vaccinations and other factors, the company stated that the difficult earnings environment in non-manufacturing industries and economic uncertainty caused by COVID-19 continue.
  14. FY2021-Q3WorsenedAnnual report

    「However, from around November, a third wave of infections began to spread again, further increasing uncertainty about the outlook for economic activity.」

    The company stated that the third wave of COVID-19 infections had further increased uncertainty about the outlook for economic activity.
  15. FY2021-Q2RestatedAnnual report

    「Since July, economic activity has resumed following the lifting of the state of emergency in Japan and the easing or lifting of lockdowns in major countries, with signs of recovery mainly in consumption and exports. However, the outlook remains uncertain due to concerns about a renewed spread of infections and other factors.」

    While recognizing the resumption of economic activity, the company reconfirmed that uncertainty about the outlook continues due to concerns about a renewed spread of infections.
  16. FY2021-Q1WorsenedAnnual report

    「Although economic activity is finally beginning to resume, the effects of COVID-19 are expected to be prolonged, and the economic outlook remains uncertain.」

    The company indicated that the stagnation and contraction of economic activity caused by COVID-19 would continue and that its impact would be prolonged.
  17. FY2020First statedAnnual report

    「If our business locations or the data centers with which we have contracts are damaged by natural disasters such as earthquakes, typhoons and tsunamis, fires, or the spread of infectious diseases, our business and results of operations may be affected. Since the beginning of the year, the spread of COVID-19 has placed domestic and overseas societies and economies in a serious situation, further increasing economic uncertainty.」

    The company first specifically disclosed the spread of COVID-19 as a risk that could affect its business locations and data centers, slow IT investment, and affect sales activities targeting new customers and progress under the medium-term management plan. The impact on the fiscal year under review was considered minor.
Moved together

"Dilution of equity value resulting from the exercise of stock acquisition rights" moved the same way as this thread, in the same document, in 4 of its 17 moves.

43★12
  1. ★This thread
  2. 1Dilution of equity value resulting from the exercise of stock acquisition rights4×
  3. 2Delays in Outsourced System Development3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Collabos's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Financial Results Presentation of 2026-06-03: "Cited as achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of COVID-19 Spread on Business Activities and Medium-Term Plan | Collabos Corporation (3908) | Komori